Reliability and stability of three common classifications for Legg-Calvé-Perthes disease

Moon Seok Park1, Chin Youb Chung, Kyoung Min Lee

  • 1Department of Orthopaedic Surgery, Seoul National University Bundang Hospital, 300 Gumi-Dong, Bundang-Gu, Sungnam, Kyungki 463-707, Korea.

Insights

The Herring lateral pillar classification is most reliable for Legg-Calvé-Perthes disease (LCPD). However, initial Herring Group A classifications may be upgraded, suggesting surgical consideration for older patients.

Area of Science:

  • Orthopaedic Surgery
  • Pediatric Orthopaedics
  • Radiographic Assessment

Background:

  • Accurate prediction of Legg-Calvé-Perthes disease (LCPD) progression is crucial for early treatment decisions.
  • Reliable classification systems are needed to guide clinical management and predict outcomes.

Purpose of the Study:

  • To evaluate the reliability and stability of three common LCPD classification systems: Herring lateral pillar, Catterall, and Salter-Thompson.
  • To determine which classification system offers the most consistent and dependable assessment of LCPD.

Main Methods:

  • Retrospective review of hip radiographs from 69 LCPD patients with serial imaging.
  • Assessment of inter- and intrarater reliability using intraclass correlation coefficients (ICCs).
  • Evaluation of classification stability through initial, fragmentation, and final ratings.

Main Results:

  • Herring lateral pillar classification demonstrated the highest interrater reliability (ICC, 0.885).
  • Catterall (ICC, 0.802) and Salter-Thompson (ICC, 0.702) showed lower interrater reliability.
  • Significant changes (upgrades) were observed in over 40% of initial classifications, particularly Herring Group A.

Conclusions:

  • The Herring lateral pillar classification is the most reliable among the evaluated systems for LCPD.
  • Clinical vigilance is required as initial Herring Group A classifications may be upgraded, especially in patients over 8 years old.
  • Consideration of surgical intervention is advised for Herring Group A patients over 8 years old due to potential disease progression.
Abstract